Download Pneumonia in the Immunocompromised

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Traveler's diarrhea wikipedia , lookup

Cryptosporidiosis wikipedia , lookup

Gastroenteritis wikipedia , lookup

Staphylococcus aureus wikipedia , lookup

Oesophagostomum wikipedia , lookup

Sexually transmitted infection wikipedia , lookup

Carbapenem-resistant enterobacteriaceae wikipedia , lookup

Legionella wikipedia , lookup

Dirofilaria immitis wikipedia , lookup

Anaerobic infection wikipedia , lookup

Neonatal infection wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Human cytomegalovirus wikipedia , lookup

Transcript
Pneumonia in the Immunocompromised
21/10/10
PY Mindmaps
- the numbers of immunocompromised patients is increasing c/o improved solid-organ and
haemopoietic transplants and the expanded use of immunomodulatory therapies.
- pulmonary infections = most frequent complication with high mortality
HISTORY
< 30 days post transplant – bacteria, fungi, HSV, respiratory viruses
2-6 months post transplant – bacteria, fungi, CMV, EBV, Pneumocystis carinii, Listeria
> 6 months post transplant – community viruses and bacteria, opportunistic infections
EXAMINATION
- signs may be not as fulminant c/o obtunded immunological response
INVESTIGATIONS
CXR
Local Infiltrates
Diffuse Infiltrates
-
-
gram –ve rods
staph aureus
aspergillus
malignancy
Cryptococcus
nocardia
mucomycosis
pneumocystis carinii
Tb
legionella
radiation pneumonitis
CMV
HSV
pneumocystis carinii
drug reaction
non-specific pneumonitis
advanced aspergillus
malignancy
TRALI
- to see list of pathogens associated with the different types of immunodeficiency see
“Infectious Diseases – Specific Infections and Causative Organisms” document
Sputum
- low sensitivity
- indicated as upper respiratory tract organisms likely to be causing pneumonia
Bronchoscopy
- consider early in management once infiltrate appears
- provides diagnosis in 50-80% of cases
Jeremy Fernando (2011)
- BAL is very reliable technique
Open Lung Biopsy
- rare, but diagnostic yield high
CT Chest
- important in the diagnosis of invasive pulmonary aspergillosis: halo sign (haemorrhage
pulmonary nodule), air-crescent sign (cavitation)
- if CXR looks normal -> get CT
MANAGEMENT
Bacterial infection –> cefuroxime + erythromycin -> imipenem
CMV –> focarnet, ganciclovir
Pneumocysttis jiroveci (carinii)
-> trimethoprim-sulphamethoxazole
- corticosteroids should be used in those with HIV + hypoxia: prednisone 1mg/kg Q12hrly for
5 days
Invasive Pulmonary Aspergillous
- neutropenic = most susceptible
- can perform surveillance with galacto-mannan (polysaccharide antigen of A. fumigatus)
-> voriconazole or amphortericin B or itraconazole
Candida
- only truly pathogenic if fungaemia or lung tissue invasion demonstrated
-> caspofungin (acts against Aspergillous too)
Cryptococcus neoformans
-> amphortericin B +/- flucytosine
Jeremy Fernando (2011)